PMC6700293_01
Computed Tomography (CT) scan of target lesions during therapy with CDK4/6 inhibitors. (A) Case report 1, sternal lesion at baseline (longest diameter: 47.7 mm). (B) Case report 1, sternal lesion at best response (longest diameter: 42.91 mm). (C) Case report 2, largest liver metastasis at baseline (longest diameter: 35.74 mm). (D) Case report 2, largest liver metastasis at best response (longest diameter: 22.38 mm).
fonc-09-00759-g0001.jpg
PMC6700293_02_fonc-09-00759-g0001.jpg
F1
After 5 months of treatment, she reported resolution of dyspnea with PS improvement, and a significant response was observed by CT scan [best response by RECIST critera: PR; Figures 1C,D]. At the last visit (April 2019), the patient is currently on treatment with no evidence of disease progression (DOR: 7 months).
PMC6700293_02
Computed Tomography (CT) scan of target lesions during therapy with CDK4/6 inhibitors. (A) Case report 1, sternal lesion at baseline (longest diameter: 47.7 mm). (B) Case report 1, sternal lesion at best response (longest diameter: 42.91 mm). (C) Case report 2, largest liver metastasis at baseline (longest diameter: 35.74 mm). (D) Case report 2, largest liver metastasis at best response (longest diameter: 22.38 mm).
fonc-09-00759-g0001.jpg
PMC6700293_02_fonc-09-00759-g0001.jpg
F1
After 5 months of treatment, she reported resolution of dyspnea with PS improvement, and a significant response was observed by CT scan [best response by RECIST critera: PR; Figures 1C,D]. At the last visit (April 2019), the patient is currently on treatment with no evidence of disease progression (DOR: 7 months).